ALTAMONTE SPRINGS, Florida., October 13, 2022 /PRNewswire/ — The American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) is pleased to announce the publication of the Patient Portala platform for patients and healthcare providers to learn more about ketamine as a treatment for pain and mood disorders.

Recent breakthroughs in the use of ketamine are changing the landscape of emerging treatment options for patients managing pain and mood disorders. The wide range of information about ketamine in news articles, blogs, and magazines can be confusing for the public looking to find out more.

As a leader in ketamine education and research, ASKP3 has the expertise to speak about the ethical clinical use of ketamine in the best interests of patients from the perspective of the medical community.

New Patient Portal was developed in consultation with medical providers and patient advocates, supported by the latest research compiled by ASKP3 members, ketamine specialists. The portal offers comprehensive, factual information about ketamine, including an introduction to ketamine and how it is used to treat pain and mood disorders, what patients should consider when determining whether treatment ketamine is right for them and what to expect from treatment. The Patient Portal also contains information for loved ones supporting patients, what to look for in a clinic, and ways patients can become more involved in advocating for their healthcare.

The goal of the Patient Portal is to help patients and the wider medical community become better informed about ketamine as a medicine. ASKP3 plans to expand this site with new information as research progresses in the hope that by bringing the medical community together, patients will become more empowered to find the best care for their medical needs.

Sandhya PrashadMD, Medical Director of Houston Ketamine Therapeutics and President of ASKP3, said today, “There is a lot of confusing information on the internet about ketamine. community regarding ketamine as a treatment option, based on neutral and evidence-based science, to help patients make informed decisions about their healthcare.

About ASKP3: The American Society of Ketamine Physicians, Psychotherapists, and Practitioners is a non-profit organization comprised of a group of professionals dedicated to the safe and effective clinical use of ketamine for mental health disorders and chronic pain. With over 500 active members worldwide, ASKP3 is in a unique position to raise awareness and further educate on the safe, effective and ethical use of ketamine therapy.

CLICK HERE to access the ketamine patient portal.

Contact: Melanie DixonCAE
Executive Director

SOURCE American Society of Physicians, Psychotherapists, and Ketamine Practitioners


Comments are closed.